Introduction
Artificial intelligence (AI) is becoming ubiquitous in our society. Nowhere are the implications more pronounced than in medicine. With more than 690 Food and Drug Administration-approved AI products, AI is already helping to schedule patient appointments, determine staffing levels in emergency rooms or transcribe clinical notes.1 It has long been involved in diagnostic support such as in radiology and is currently even supporting healthcare professionals (HCPs) in clinical decision-making.2 Of significance is the rise of patient-facing AIs. Today, patients themselves are starting to interact with AI in the context of their own healthcare, for example, by using AI-driven chatbots. Even generalist chatbots such as ChatGPT or Gemini are being used by patients for health information, diagnosis and treatment planning. Recent studies have suggested that up to 25% of the population currently uses generalist AI chatbots for these purposes with up to 80% of the public…